Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 After Concorde.

× No keyword cloud information.

10 in total

1. Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus.

Authors: D D Richman; J M Grimes; S W Lagakos
Journal: J Acquir Immune Defic Syndr (1988) Date: 1990

2. Doubt cast on zidovudine's use in delaying AIDS.

Authors: L Dillner
Journal: BMJ Date: 1993-04-10

3. HIV is active even in latency, say scientists.

Authors: S Connor
Journal: BMJ Date: 1993-04-10

4. Preliminary analysis of the Concorde trial. Concorde Coordinating Committee.

Authors: J P Aboulker; A M Swart
Journal: Lancet Date: 1993-04-03 Impact factor: 79.321

5. Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex.

Authors: F A Schmitt; J W Bigley; R McKinnis; P E Logue; R W Evans; J L Drucker
Journal: N Engl J Med Date: 1988-12-15 Impact factor: 91.245

6. Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality.

Authors: M Tersmette; J M Lange; R E de Goede; F de Wolf; J K Eeftink-Schattenkerk; P T Schellekens; R A Coutinho; J G Huisman; J Goudsmit; F Miedema
Journal: Lancet Date: 1989-05-06 Impact factor: 79.321

7. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease.

Authors: G Pantaleo; C Graziosi; J F Demarest; L Butini; M Montroni; C H Fox; J M Orenstein; D P Kotler; A S Fauci
Journal: Nature Date: 1993-03-25 Impact factor: 49.962

8. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.

Authors: M A Fischl; D D Richman; M H Grieco; M S Gottlieb; P A Volberding; O L Laskin; J M Leedom; J E Groopman; D Mildvan; R T Schooley
Journal: N Engl J Med Date: 1987-07-23 Impact factor: 91.245

9. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.

Authors: M A Fischl; D D Richman; N Hansen; A C Collier; J T Carey; M F Para; W D Hardy; R Dolin; W G Powderly; J D Allan
Journal: Ann Intern Med Date: 1990-05-15 Impact factor: 25.391

10. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.

Authors: P A Volberding; S W Lagakos; M A Koch; C Pettinelli; M W Myers; D K Booth; H H Balfour; R C Reichman; J A Bartlett; M S Hirsch
Journal: N Engl J Med Date: 1990-04-05 Impact factor: 91.245

10 in total

3 in total

After Concorde.